S. Battaglia

发表

Early Fracture Healing is Delayed in the Col1a2+/G610C Osteogenesis Imperfecta Murine Model

P. Layrolle, S. Villani, A. Forlino, 2018, Calcified Tissue International.

Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.

G. Finet, J. Dubois-Randé, J. Lusson, 1997, Circulation.

Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid

M. Heymann, D. Heymann, F. Duteille, 2008, International journal of cancer.

Oxytocin Reverses Osteoporosis in a Sex-Dependent Manner

M. Scheideler, C. Roux, D. Heymann, 2015, Front. Endocrinol..

Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.

G. Moriceau, C. Riganti, M. Denis, 2010, Cancer research.

Sex-specific autophagy modulation in osteoblastic lineage: a critical function to counteract bone loss in female

G. Carle, V. Pierrefite-Carle, D. Heymann, 2016, Oncotarget.

Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.

O. Delattre, F. Tirode, D. Heymann, 2010, Cancer research.

Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds.

M. Heymann, D. Heymann, J. Davaine, 2012, Cytokine.

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration

D. Heymann, F. Gouin, F. Redini, 2014, BMC Cancer.

Conditioned media from mouse osteosarcoma cells promote MC3T3‐E1 cell proliferation using JAKs and PI3‐K/Akt signal crosstalk

L. Shultz, D. Heymann, K. Mori, 2008, Cancer science.

Autophagy in osteoblasts is involved in mineralization and bone homeostasis

D. Dempster, G. Carle, V. Pierrefite-Carle, 2014, Autophagy.

Oxytocin reverses ovariectomy-induced osteopenia and body fat gain.

S. Luquet, G. Ailhaud, J. Castel, 2014, Endocrinology.

Cancer esearch apeutics , Targets , and Chemical Biology dronic Acid as a New Adjuvant Therapeutic Strategy R Ewing ' s Sarcoma Patients

O. Delattre, F. Tirode, D. Heymann, 2010 .

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

D. Heymann, B. Ory, F. Blanchard, 2015, International journal of cancer.

NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate.

D. Heymann, B. Ory, F. Redini, 2014, Cancer letters.

Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo

D. Heymann, K. Mori, F. Blanchard, 2008, Clinical Cancer Research.

Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression

F. Verrecchia, D. Heymann, B. Ory, 2015, Clinical Cancer Research.

Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model.

V. Escriou, P. Layrolle, D. Heymann, 2015, Acta biomaterialia.

Carotid and femoral atherosclerotic plaques show different morphology.

M. Krempf, M. Heymann, D. Heymann, 2011, Atherosclerosis.

Severe compromise of preosteoblasts in a surgical mouse model of bisphosphonate-associated osteonecrosis of the jaw.

D. Heymann, L. Córdova, F. Redini, 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Direct comparison of current cell-based and cell-free approaches towards the repair of craniofacial bone defects - A preclinical study.

R. Khonsari, J. Sohier, P. Corre, 2015, Acta biomaterialia.

Enhanced human bone marrow mesenchymal stromal cell adhesion on scaffolds promotes cell survival and bone formation.

P. Layrolle, P. Hernigou, N. Chevallier, 2017, Acta biomaterialia.

Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells

D. Aubert, P. Arbuthnot, N. Ferry, 2012, PloS one.

Direct anti‐cancer effect of oncostatin M on chondrosarcoma

D. Heymann, F. Gouin, F. Blanchard, 2011, International journal of cancer.

Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

M. Heymann, D. Heymann, F. Gouin, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies.

D. Heymann, J. Farges, F. Redini, 2014, Bone.

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model

T. Helleday, V. Gorgoulis, D. Heymann, 2020, EBioMedicine.

Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models

D. Scherman, V. Escriou, D. Heymann, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.

B. Pitard, D. Heymann, F. Gouin, 2007, Cancer research.

Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2010 .

Jaw osteosarcoma models in mice: first description

D. Heymann, P. Corre, A. Moreau, 2019, Journal of translational medicine.

OPG, RANK and RANK ligand expression in thyroid lesions

M. Heymann, D. Heymann, J. Paineau, 2008, Regulatory Peptides.

DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.

B. Le Goff, D. Heymann, K. Mori, 2007, Bone.

Direct anti-cancer effect of oncostatin M on chondrosarcoma

D. Heymann, F. Blanchard, F. Redini, 2011 .

Early Fracture Healing is Delayed in the Col1a2+/G610C Osteogenesis Imperfecta Murine Model

P. Layrolle, S. Villani, A. Forlino, 2018, Calcified Tissue International.

Impact of onco-pediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

M. Heymann, D. Heymann, F. Gouin, 2011 .

Therapeutic efficacy of soluble receptor activator of NF-kB (RANK) delivered by non viral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2008 .

P47. Therapeutic efficacy of soluble receptor activator of NF-kappaB delivered by non-viral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2008 .

Jaw osteosarcoma models in mice: first description

D. Heymann, P. Corre, A. Moreau, 2019, Journal of Translational Medicine.

Therapeutic efficacy of soluble receptor activator of nuclear factor-κB-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma

D. Heymann, F. Redini, S. Battaglia, 2008, Molecular Cancer Therapeutics.

Zoledronic Acid Activates the DNA S-Phase Checkpoint and Induces Osteosarcoma Cell Death Characterized by Apoptosis-Inducing Factor and Endonuclease-G Translocation Independently of p53 and Retinoblastoma Status

S. Battaglia, D. Heymann, F. Gouin, 2007, Molecular Pharmacology.